| Dr Nancy P Wiggins, OD | |
|
2576 Brodhead Rd, Aliquippa, PA 15001-4380 | |
| (724) 378-8585 | |
| (724) 375-1574 |
| Full Name | Dr Nancy P Wiggins |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 33 Years |
| Location | 2576 Brodhead Rd, Aliquippa, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821063470 | NPI | - | NPPES |
| 0012669200005 | Medicaid | PA | |
| 710504 | Other | PA | HIGHMARK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OEG000668 (Pennsylvania) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optometric Care, Inc | 5799722732 | 3 |
News Archive
Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson's disease.
Results of a retrospective study suggest that around a quarter of patients with schizophrenia receive antipsychotic polypharmacy, despite a lack of evidence for the approach.
Astellas Pharma Inc. announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals, Inc. to 5:00 p.m. New York City time on Monday, May 17, 2010, unless further extended.
A new study led by the Keck School of Medicine of University of Southern California (USC) reveals that older adults with elevated levels of brain-clogging plaques, yet normal cognition, experience faster mental decline, suggestive of Alzheimer's disease. The study published in The Journal of the American Medical Association on June 13 presented the earliest precursor—the toxic and sticky protein as part of the disease, before symptoms arise.
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
› Verified 2 days ago
| Provider Name | Optometric Care, Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1992713184 PECOS PAC ID: 5799722732 Enrollment ID: O20050412000579 |
News Archive
Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson's disease.
Results of a retrospective study suggest that around a quarter of patients with schizophrenia receive antipsychotic polypharmacy, despite a lack of evidence for the approach.
Astellas Pharma Inc. announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals, Inc. to 5:00 p.m. New York City time on Monday, May 17, 2010, unless further extended.
A new study led by the Keck School of Medicine of University of Southern California (USC) reveals that older adults with elevated levels of brain-clogging plaques, yet normal cognition, experience faster mental decline, suggestive of Alzheimer's disease. The study published in The Journal of the American Medical Association on June 13 presented the earliest precursor—the toxic and sticky protein as part of the disease, before symptoms arise.
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
› Verified 2 days ago
| Provider Name | Premier Eyecare Of Cranberry Inc. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1215364351 PECOS PAC ID: 4587893193 Enrollment ID: O20140131000003 |
News Archive
Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson's disease.
Results of a retrospective study suggest that around a quarter of patients with schizophrenia receive antipsychotic polypharmacy, despite a lack of evidence for the approach.
Astellas Pharma Inc. announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals, Inc. to 5:00 p.m. New York City time on Monday, May 17, 2010, unless further extended.
A new study led by the Keck School of Medicine of University of Southern California (USC) reveals that older adults with elevated levels of brain-clogging plaques, yet normal cognition, experience faster mental decline, suggestive of Alzheimer's disease. The study published in The Journal of the American Medical Association on June 13 presented the earliest precursor—the toxic and sticky protein as part of the disease, before symptoms arise.
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy P Wiggins, OD 2576 Brodhead Rd, Aliquippa, PA 15001-4380 Ph: (724) 378-8585 | Dr Nancy P Wiggins, OD 2576 Brodhead Rd, Aliquippa, PA 15001-4380 Ph: (724) 378-8585 |
News Archive
Great Lakes NeuroTechnologies (GLNT) announced today that they are launching a study to determine the feasibility of using intelligent algorithms to assist with programming deep brain stimulation settings for Parkinson's disease.
Results of a retrospective study suggest that around a quarter of patients with schizophrenia receive antipsychotic polypharmacy, despite a lack of evidence for the approach.
Astellas Pharma Inc. announced today that it has extended its all-cash tender offer for $52 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals, Inc. to 5:00 p.m. New York City time on Monday, May 17, 2010, unless further extended.
A new study led by the Keck School of Medicine of University of Southern California (USC) reveals that older adults with elevated levels of brain-clogging plaques, yet normal cognition, experience faster mental decline, suggestive of Alzheimer's disease. The study published in The Journal of the American Medical Association on June 13 presented the earliest precursor—the toxic and sticky protein as part of the disease, before symptoms arise.
Incomplete diagnostic investigation and failure to get the best treatment are the most likely reasons why survival for bowel cancer patients is lower in the UK than in other comparable countries, according to new research published in the journal Acta Oncologica.
› Verified 2 days ago
Aaron Joseph Harsch, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2576 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-8585 Fax: 724-375-1574 | |
Dr. Holly E Caputy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2576 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-8585 Fax: 724-375-1574 | |
Dr. Scott Galen Smith, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2116 Sheffield Rd, Aliquippa, PA 15001 Phone: 724-378-2880 Fax: 724-378-0450 | |
Lisa R Kanfoush Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 131 Pleasant Dr Ste 4u, Aliquippa, PA 15001 Phone: 724-622-6467 Fax: 724-378-4547 | |
Dr. Arnold R Eger, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2576 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-8585 Fax: 724-375-1574 | |
Dr. Devin G Depner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2576 Brodhead Rd, Aliquippa, PA 15001 Phone: 724-378-8585 Fax: 724-375-1574 |